US Patent 11883408 Reboxetine to treat narcolepsy
Patent 11883408 was granted and assigned to axsome therapeutics, inc. on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Feb, 2024
Golden AI
Edits made to:
Infobox (+14 properties)
Article (+464 characters)
US Patent 11883408 Reboxetine to treat narcolepsy
Article
Patent abstract
Described herein are methods of treating narcolepsy with cataplexy, comprising administering reboxetine to a human being in need thereof. Reboxetine may also be used in the manufacture of a medicament for the treatment of narcolepsy with cataplexy. Also disclosed herein are kits comprising a pharmaceutical composition comprising reboxetine and instructions to use the pharmaceutical composition to treat narcolepsy with cataplexy in a human being.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Herriot Tabuteau0
Date of Patent
January 30, 2024
0Patent Application Number
177514900
Date Filed
May 23, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11883408 Reboxetine to treat narcolepsy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.